Cited by 418Computational Drug Discovery MethodsChemical Synthesis and AnalysisSynthesis and Characterization of Heterocyclic Compounds

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

Open access

Sadybekov, Arman A., Sadybekov, Anastasiia V., Liu, Yongfeng, Iliopoulos-Tsoutsouvas, Christos, Huang, Xi-Ping, Pickett, Julie, Houser, Blake, Patel, Nilkanth, Tran, Ngan K., Tong, Fei, Zvonok, Nikolai, Jain, Manish K., Savych, Olena, Radchenko, Dmytro S., Nikas, Spyros P., Petasis, Nicos A., Moroz, Yurii S., Roth, Bryan L., Makriyannis, Alexandros, Katritch, Vsevolod·2022·Nature

DOI 10.1038/s41586-021-04220-9PMC PMC9763054

Open this paper in CoChat — free account

Abstract

Structure-based virtual ligand screening is emerging as a key paradigm for early drug discovery owing to the availability of high-resolution target structures 1-4 and ultra-large libraries of virtual compounds 5,6. However, to keep pace with the rapid growth of virtual libraries, such as readily available for synthesis (REAL) combinatorial libraries 7, new approaches to compound screening are needed 8,9. Here we introduce a modular synthon-based approach-V-SYNTHES-to perform hierarchical structure-based screening of a REAL Space library of more than 11 billion compounds. V-SYNTHES first identifies the best scaffold-synthon combinations as seeds suitable for further growth, and then iteratively elaborates these seeds to select complete molecules with the best docking scores. This hierarchical combinatorial approach enables the rapid detection of the best-scoring compounds in the gigascale chemical space while performing docking of only a small fraction (<0.1%) of the library compounds. Chemical synthesis and experimental testing of novel cannabinoid antagonists predicted by V-SYNTHES demonstrated a 33% hit rate, including 14 submicromolar ligands, substantially improving over a standard virtual screening of the Enamine REAL diversity subset, which required approximately 100 times more computational resources. Synthesis of selected analogues of the best hits further improved potencies and affinities (best inhibitory constant (K i) = 0.9 nM) and CB 2/CB 1 selectivity (50-200-fold). V-SYNTHES was also tested on a kinase target, ROCK1, further supporting its use for lead discovery. The approach is easily scalable for the rapid growth of combinatorial libraries and potentially adaptable to any docking algorithm.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-021-04220-9

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196 · cited 3×
“The remaining compounds were filtered with PAINS score, drug-likeness properties, chemical diversity as well as ligand interaction diversity to sample different binding modes in the pocket.”
Influential
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,096
Self-citation
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998 · cited 2×
“Recently, ultra-large libraries of more than 100 million readily accessible (REAL) compounds have been developed and used in docking-based VLS, yielding high-quality hits for lead discovery 5,6 .”
MethodInfluentialSelf-citation
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H., & Peterson, J. R. (2011) · Nature Biotechnology · doi:10.1038/nbt.2017 · Cited by 919 · cited 1×
“The HotSpot radiometric assay (Reaction Biology Corporation) measures inhibition of ROCK1 catalytic activity towards a specific peptide substrate (KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK), which is monitored by P81 filter-binding methods 45 .”
Method
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755 · cited 4×
“The Tango arrestin recruitment assays were performed as previously described 23 .”
MethodInfluentialSelf-citation
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1188 · Cited by 721 · cited 1×
“The approach is applied here to cannabinoid receptors, which are class A G-protein-coupled receptors (GPCRs), and are key targets in drug discovery for inflammatory disorders, neurodegenerative diseases and cancer 17–19 .”
Background
Crystal Structure of the Human Cannabinoid Receptor CB1
Hua, T., Vemuri, K. V., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.004 · Cited by 702
Self-citation
An open-source drug discovery platform enables ultra-large virtual screens
Gorgulla, C., Boeszoermenyi, A., Wang, Z., Fischer, P. D., Coote, P. W., Das, K. M., Malets, Y. S., Radchenko, D. S., Moroz, Y. S., Scott, D. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2117-z · Cited by 677 · cited 2×
“Two binding modes for the CB 2 receptor binding pocket were prepared: one guided by 20 known antagonists and another by 20 agonists, selected from ChEMBL high-affinity ligands for CB 2 (CHEMBL253, affinity p Kd > 8).”
MethodInfluentialSelf-citation
Cryo-EM in drug discovery: achievements, limitations and prospects
Renaud, J., Chari, A., Ciferri, C., Liu, W.-T., Rémigy, H., Stark, H., & Wiesmann, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.77 · Cited by 473 · cited 1×
“The affinities ( K i ) of the new compounds for rat CB 1 receptors and human CB 2 receptors were obtained using membrane preparations from rat brain or HEK293 cells, respectively, and [ 3 H]CP-55,940 as the radioligand, as previously described 42,43 .”
Method

Show all 43 references

Sorted by citations

Items 301–400 of 418

Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual Screening
Shi, Z., Liu, N., Zhao, F., Kang, D., Jonghe, S. D., Neyts, J. H., Gao, N., & Liu, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125625 · Cited by 2
“Virtual screening is powerful enough to discover novel molecules with different scaffolds [18,19], which can mitigate scale, time, and cost issues compared to conventional experimental approaches [20–22].”
Generating multimillion chemical space based on the Ugi four-center three-component reaction with oxocarboxylic acids
Govor, E. V., Dymura, S., Viniichuk, O., Naumchyk, V., Zhemera, A. V., Radchenko, D. S., & Grygorenko, O. O. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11410-4 · Cited by 1
“High-performance molecular docking [5] implemented into hierarchical structure-based virtual screening (V-SYNTHES) [6], an open-source drug discovery platforms (VirtualFlow) [7], or combined with fragment-based drug discovery [8] enabled efficient discovery of potent hits with unique chemical struc…”
Self-citation
Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis
Kenny, S. E., Antaw, F., Locke, W. J., Howard, C. B., Korbie, D. J., & Trau, M. (2022) · Life · doi:10.3390/life12030363 · Cited by 2
“Recently, it has been reported that virtual libraries of up to 11 billion compounds can be screened [84].”
Background
Drug building blocks and libraries at risk in Ukraine
Kondratov, I. S., Moroz, Y. S., Irwin, J. J., & Shoichet, B. K. (2022) · Science · doi:10.1126/science.abq7841 · Cited by 2
Self-citation
Unsupervised Learning‐Guided Accelerated Discovery of Alkaline Anion Exchange Membranes for Fuel Cells
Zou, X., Xu, G., Fang, P., Li, W., Jin, Z., Guo, S., Hu, Y., Li, M., Pan, J. S., Sun, Z., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202300388 · Cited by 2
Deep Learning Strategies for Enhanced Molecular Docking and Virtual ScreeningPreprint
da Silva, M. M. P., Guedes, I. A., Custódio, F. L., Krempser, E., & Dardenne, L. E. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-zfv87-v2 · Cited by 2
Structure‐Based Ultra‐Large Virtual Screenings
Gorgulla, C. (2024) · Wiley eBooks · doi:10.1002/9783527840748.ch19 · Cited by 2
NGT: Generative AI with Synthesizability Guarantees Identifies Potent Inhibitors for a G-protein Associated Melanocortin Receptor in a Tera-scale vHTS ScreenPreprint
de Oliveira, S. H. P., Pedawi, A., Kenyon, V. A., & van den Bedem, H. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-fz37h · Cited by 1
Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based ModelingPreprint
Warapande, V., Meng, F., Bozan, A., Graff, D., Fromer, J. C., Mughal, K., Mohideen, F. K., Shivangi, S., Paruchuri, S., Johnston, M. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636334 · Cited by 3
ViSAS for Entering Chemical Space: Virtual Screening of Analog Series and Related AdvancesPreprint
Naveja-Romero, J. J., Saldívar-González, F. I., Prado-Romero, D. L., Ruiz-Moreno, A. J., Velasco-Velázquez, M. A., Miranda-Quintana, R. A., & Medina‐Franco, J. L. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-9t2rj · Cited by 2
Scrutinization on Docking against Individually Generated Target Pockets for each Ligand
Zhan, R., Zhang, W., & Huang, J. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101759 · Cited by 2
Using Zebrafish to Study the Mechanisms That Underlie Down Syndrome
Moyer, A. J., & Thyme, S. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-78611-2_6 · Cited by 1
Experimental Assays: Chemical Properties, Biochemical and Cellular Assays,and In Vivo Evaluations
Serafim, M. S. M., Reis, E. V. D. S., Coelho-dos-Reis, J. G. A., Abrahão, J. S., & O’Donoghue, A. J. (2024) · Computer-aided drug discovery and design · doi:10.1007/978-3-031-76718-0_12 · Cited by 1
Cannabinoid receptors as targets for drug discovery
Iliopoulos‐Tsoutsouvas, C., Iyer, M. R., & Makriyannis, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00052-2 · Cited by 1
Self-citation
Combining AlphaFold with Focused Virtual Library Design in the Development of Novel CCR2 and CCR5 Antagonists
Essa, K., van der Dussen, K. N., Yao, Y., Bleijs, B. T. M., Zacarı́as, N. V. O., Heitman, L. H., van Westen, G. J. P., Jespers, W., van der Es, D., & Šícho, M. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01596 · Cited by 1
SLICE (SMARTS and Logic In ChEmistry): fast generation of molecules using advanced chemical synthesis logic and modern coding style
Ilemo, S. N., Delannée, V., Grushin, O., Judson, P. N., Patel, H., Nicklaus, M. C., & Tarasova, N. I. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01119-9 · Cited by 1
Selected food additives for inhibiting the metastable polymorphic transformation of baricitinib: a novel and safe strategy
Zhang, X., Wang, L., Tao, X., Li, H., Qu, Y., Han, P., & Song, W. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126823 · Cited by 1
Unlocking Selenium Chemical Space via a Programmable Synthesis Platform Bearing Cannabinoid Receptor Recognition Motifs
Iyer, M. R., Bhattacharjee, P., Dutta, S., Lobe, M. M. M., Volesky, P. D., Godlewski, G., Puhl, H. L., & Hassan, S. A. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16359 · Cited by 1
Agentic AI Workflow for Virtual Screening with Docking, ADMET Filtering, and Human Hit Triage
Herrera, L., Rojas, D., & Castro, A. (2026) · Pharmacophore · doi:10.51847/mkbuv8ird5 · Cited by 1
Modeling the Sensitivity of Large-Scale Virtual Screening to Scoring Function Accuracy, Artifacts, and Library Composition
Moesgaard, L., Shoichet, B. K., & Mailhot, O. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01066 · Cited by 1
Self-evolving artificial intelligence virtual cells: A closed-loop system from multi-scale modeling to biomedical applications
Hu, C., Zhang, C., Lu, X., Zhang, X., Pan, S., Xu, H., Lok, S. C., Zhang, M., & Wong, I. N. (2026) · Chinese Medical Journal BioMed · doi:10.65457/cmjbm-2026-0006 · Cited by 1
G-screen: scalable protein-aware virtual screening through flexible ligand alignment
Jung, N., Park, H., Yang, J., & Seok, C. (2026) · Journal of Cheminformatics · doi:10.1186/s13321-026-01297-0 · Cited by 1
Structure based discovery of antipsychotic-like TAAR1 agonists
Huang, S., Liu, H., Wu, Y., Braz, J. M., Kranthi, D., Hall, B. W., Zhang, X., Radchenko, D. S., Moroz, Y. S., Irwin, J. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77484-2 · Cited by 1
Self-citation
Ensemble-based virtual screening of human PI4KIIIα inhibitors toward the Hepatitis C virus
Wang, C., Gao, Y., Gu, J., Chen, H., Yin, Z., Zhu, H., & Zhu, T. (2023) · Chemical Physics Letters · doi:10.1016/j.cplett.2023.140354 · Cited by 1
Drug discovery processes: When and where the rubber meets the road
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00025-0 · Cited by 1
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation
Dou, X., Sun, Q., Liu, Y., Lu, Y., Zhang, C., Xu, G., Xu, Y., Huo, T., Zhao, X., Su, L., et al. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129547 · Cited by 1
Self-citation
Considerations Around Structure-Based Drug Discovery for KRAS Using DOCK
Chakrabarti, M., Tan, Y. S., & Balius, T. E. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3822-4_6 · Cited by 1
Lighting and rapid detection of the Coronavirus S protein using computationally speculated ligand and its application in SARS-CoV-2
Liu, Y., Xie, X., Wang, Q., Chen, D., Qiu, D., Yan, X., Guo, L., Chen, Q., Zhang, X., & Ju, H. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136284 · Cited by 1
Self-citation
Membrane Proteins: Targets That Should Not Be Overlooked for Assessing Human and Ecological Health Effects of Chemicals
Zhang, H., Ihara, M., & Chen, J. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c05367 · Cited by 1
Drug design and repurposing with a sequence-to-drug paradigmPreprint
Chen, L., Fan, Z., Chang, J., Yang, R., Guo, H., Zhang, Y., Yang, T., Zhou, C., Chen, Z., Zheng, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.26.485909 · Cited by 1
Augmented Memory: Capitalizing on Experience Replay to Accelerate De Novo Molecular DesignPreprint
Guo, J., & Schwaller, P. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-qmqmq · Cited by 1
Augmented Memory: Capitalizing on Experience Replay to Accelerate De Novo Molecular DesignPreprint
Guo, J., & Schwaller, P. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-qmqmq-v3 · Cited by 3
DOCK Blaster 2.0 - Automated Optimization of Docking Models using Retrospective DockingPreprint
Knight, I., Tang, K. G., Mailhot, O., & Irwin, J. J. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-6h2c9-v2
Deep Learning Strategies for Enhanced Molecular Docking and Virtual ScreeningPreprint
da Silva, M. M. P., Guedes, I. A., Custódio, F. L., da Silva, E. K., & Dardenne, L. E. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-zfv87
NGT: Generative AI with Synthesizability Guarantees Identifies Potent Inhibitors for a G-protein Associated Melanocortin Receptor in a Tera-scale vHTS ScreenPreprint
de Oliveira, S. H. P., Pedawi, A., Kenyon, V. A., & van den Bedem, H. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-fz37h-v2 · Cited by 1
qcMol: a large-scale dataset of 1.2 million molecules with high-quality quantum chemical annotations for molecular representation learningPreprint
Wang, H., Zhang, Z., & Gong, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.07.674462 · Cited by 1
HIV Sero Conversion in Urban Rwandan Women Before and After a Prevention Programme
Allen, S. A., Serufilira, A., de Perre, P. V., Lindan, C., Tice, J., Hulley, S. B., & Black, D. M. (1990)
Innovative chemistry yields potential antidepressant drugs
(2022) · Nature · doi:10.1038/d41586-022-03020-z
DOCK Blaster 2.0 - An Investigation of Automated DockingPreprint
Knight, I., Tang, K. G., & Irwin, J. J. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-6h2c9
Drug discovery: Standing on the shoulders of giants
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8
Correlation of binding site properties with chemistries used for generation of ultra-large virtual libraries.Preprint
Song, R., Nicklaus, M. C., & Tarasova, N. I. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-hs7ql
A New Optimized Hybridization Approach for in silico High Throughput Molecular Docking on FPGA Platform
Jarrah, A. A., & Lababneh, J. (2023) · Current Computer - Aided Drug Design · doi:10.2174/1573409919666230503094411
Zero-shot Learning of Drug Response Prediction for Preclinical Drug ScreeningPreprint
Hu, W., Li, K., Liu, W., Luo, Y., Cai, X., & Du, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3405152/v1 · Cited by 2
Protein structure-based organic chemistry-driven ligand design from ultra-large chemical spacesPreprint
Rognan, D., Sindt, F., Seyller, A., & Eguida, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3687338/v1
G-Protein Coupled Receptor Gpr-1 Is Important for the Growth and Nutritional Metabolism of an Invasive Bark Beetle Symbiont Fungi Leptographium procerum
Ye, F., Kang, Z., Kou, H., Yang, Y., Chen, W., Wang, S., Sun, J., & Liu, F. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c07547
Structure-based Design for Medicinal Chemists
Blaney, J., & Davis, A. M. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00137
A virtual library of small molecules mimicking dipeptides
Lim, V. J. Y., Gerber, H., Schihada, H., Trinh, V. T., Hilger, D., Vázquez, O., & Kolb, P. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202300636
PackDock: a Diffusion Based Side Chain Packing Model for Flexible Protein-Ligand DockingPreprint
Zheng, M., Zhang, R., Jiang, X., Cao, D., Yu, J., Chen, M., Fan, Z., Kong, X., Xiong, J., Zhang, Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4128729/v1
Microbial Antioxidants and Their Interactions with Gastrointestinal Tract Epithelial Cells in the CattlePreprint
Sun, H., Zhu, S., Jia, M., Li, H., Han, B., Shi, T., Zhang, Q., Zheng, W., Xu, J., Chen, L., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4193125/v1
NGT: Generative AI with Synthesizability Guarantees Identifies Potent Inhibitors for a G-protein Associated Melanocortin Receptor in a Tera-scale vHTS ScreenPreprint
de Oliveira, S. H. P., Pedawi, A., Kenyon, V. A., & van den Bedem, H. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-fz37h-v3
PackDock is a Flexible Protein-Ligand Docking Approach with Diffusion-Based Side Chain PackingPreprint
Zheng, M., Zhang, R., Jiang, X., Cao, D., Wang, Z., Yu, J., Chen, M., Fan, Z., Kong, X., Xiong, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5429173/v1
The Influence of Artificial Intelligence in Drug Discovery and Development
Krishnan, S., Rajendran, K., Yogeshwaran, V. N., & Radhakrishnan, B. (2024) · Medical virology · doi:10.1007/978-981-97-2938-8_3
Highly activated neddylation pathway in lung cancer and chemical targeted intervention
Qin, X., Yu, Q., Li, X., Xiong, X., Liu, P., Han, X., & Sun, Y. (2025) · Scientia Sinica Chimica · doi:10.1360/ssc-2025-0015
PayloadGenX, a multi-stage hybrid virtual screening approach for payload design: A microtubule inhibitor case study
Ahmed, F., Samantasinghar, A., Sunildutt, N., & Choi, K. H. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108439
Real Way to Target Gram-Negative Pathogens: Discovery of a Novel Helicobacter pylori Antibiotic Class
Propp, J., Castor, D. O., & Spies, M. A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00112
Pinpointing potent hits for cancer immunotherapy targeting the TIGIT/PVR pathway using the XGBoost model, centroid-based virtual screening, and MD simulation
Lü, X., Wang, C., Tang, M., Li, J., Xia, Z., Fan, S., Jin, Y., & Yang, Z. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108450 · Cited by 1
Structure and Pseudo-Ligand Based Drug Discovery for Disease Targets
Xie, W., Xu, Y., Zhang, W., Lai, L., & Pei, J. (2025) · Communications in computer and information science · doi:10.1007/978-981-96-3752-2_8
Resources for Accelerating Medicine Discovery
Garcia‐Paredes, M. C., Ghanekar, P. G., Chambers, R. K., Schmitt, A. D., Cavanagh, K. L., & Woerly, E. M. (2025) · Wiley eBooks · doi:10.1002/0471266949.bmc319
Structure Optimization and Binding Energy Prediction of Arylamycin Analogues Based on 3D‐QSAR and Molecular Dynamics Simulations
Ai, X., Zou, X., Zou, Y., Wang, J., & Wang, Y. (2025) · ChemistrySelect · doi:10.1002/slct.202500397
Expediting the discovery of promising photothermal cyanine molecules through a transfer learning approach
Zhang, Z., Wu, S., He, L., Cao, G., Tang, J., Pan, Z., Huang, Z., Yang, Y., Li, A., Wang, Y., et al. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf413
Parallel synthesis of 5′-amino-5′-deoxy-adenosine derivatives for focused chemical space exploration and their application as methyltransferase inhibitors
Hoba, S. N., Schwickert, M., Kammerer, L., Sabin, M. O., Weldert, A. C., Nidoieva, Z., Meidner, J. L., Barthels, F., Schirmeister, T., & Kersten, C. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00376h
The application status and development trend of artificial intelligence in chemical science - based on bibliometric and knowledge graph analysis
Xu, Y. (2025) · International Conference on Educational Digitalization and Computer Science in the Guangdong-Hong Kong-Macao Greater Bay Area · doi:10.1145/3746469.3746569
Efficient Search of Ultra-Large Synthesis On-Demand Libraries with Chemical Language ModelsPreprint
Heyer, K., Yang, D., & Diaz, D. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.04.674350
Accelerated Drug Discovery through In Silico Study and Multicomponent Reactions
Sutanto, F., Krisli, A. R., Wirawan, C., Cahya, R. J., Aliyansah, P. I., & Hartrianti, P. (2025) · Current Drug Therapy · doi:10.2174/0115748855399861250908113204
Transfer learning-enabled density prediction model for energetic molecule screening
He, Y., Tang, Y., Liu, R., Zhang, C., Yang, C., & Liu, J. (2025) · Energetic Materials Frontiers · doi:10.1016/j.enmf.2025.11.010
Additional file 1 of EasyDock: customizable and scalable docking tool
Minibaeva, G., Ivanová, A., & Полищук, П. Г. (2024) · Figshare · doi:10.6084/m9.figshare.26634585
AgainstOTE: A generative pretrain-tune framework for de novo molecular generation against off-target effects
Xu, Y., Fang, W., Wang, S., Luo, H.-B., Xu, Q., Chen, F.-E., Qu, J., & Sun, Y. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100158
Metabolic engineering of Bacillus subtilis for enhanced free heme biosynthesis by an enzyme-chassis co-optimization strategy
Diao, S., Zhou, H., Li, Y., Dai, J., Yan, D., & Wu, J. (2026) · Biotechnology Letters · doi:10.1007/s10529-025-03686-1
Rapid Parallel Virtual Screening Aids the Discovery of Novel P-Glycoprotein Inhibitors
Moesgaard, L., Pakuła, K., Nielsen, C. U., & Kongsted, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02552
Large-scale prospective evaluation of co-folding across hundreds of Mac1–ligand complexes and three virtual screensPreprint
Kim, J., Correy, G. J., Hall, B. W., Rachman, M. M., Mailhot, O., Togo, T., Gonciarz, R. L., Jaishankar, P., Neitz, R. J., Hantz, E. R., et al. (2026) · eLife · doi:10.7554/elife.110475
Anticorrosive potential of plant-derived heterocompounds for bio-corrosion: in silico and AI-driven insights
Sharma, N., Verma, A. K., Thakur, M., Kathpalia, K. V., Hassan, K., & Sharma, N. R. (2026) · Journal of Adhesion Science and Technology · doi:10.1080/01694243.2026.2614029
Evolutionary exploration of drug-like chemical space utilizing generative AI and virtual screeningPreprint
Secker, C., Secker, P. F., Yergöz, F., Celik, M. O., Chewle, S., Le, M. P. N., Masoud, M., Christgau, S., Weber, M., Gorgulla, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.26.714527
“Such approaches include Chemical Space Docking [42] and V-SYNTHES [43].”
Constructing and characterizing trillion-scale combinatorial chemical library
Su, J., Song, F. V., Huang, D., & Liao, M. (2026) · Journal of Cheminformatics · doi:10.1186/s13321-026-01185-7 · Cited by 1
“In drug screening campaigns within make-on-demand or combinatorial chemical spaces, traditional compound selection strategies typically focus on purchasing the top-scoring molecules (the highest-ranking building block pairs) [8, 20, 34].”
Design and application of deep learning methods to structure-based drug design
Volkov, M. (2023) · theses.fr (ABES) · doi:10.70675/d4a7b752z9818z4196zab21z61e5493b7907
Monte-Carlo tree search applied to structure generation
Roucairol, M. (2024) · theses.fr (ABES) · doi:10.70675/a3b9fa7fz7431z42d0z9c49z5b869c8b541b
Identification of molecular mechanisms subtending bread wheat androgenesis : A chemical biology approach
Paris, J. (2024) · doi:10.70675/ab80d11fze1c0z46f3z8738zdc1804e36989
The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules
Hall, B. W., Sakamoto, K., Huang, X.-P., Irwin, J. J., Shoichet, B. K., & Roth, B. L. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00345
Self-citation
Emerging trends and future directions in computer-aided drug design and artificial intelligence
Cao, D.-S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45105-8.00009-3
Introduction of AI in drug design
Huang, S., & Ou, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45105-8.00008-1 · Cited by 1
BiLSTM-Powered Bilinear Attention for Protein–Ligand PredictionPreprint
Cheng, C., Chen, Y.-A., Li, F.-Y., & Re, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.10.724184
Integrating 19 Focused Screening with Make‐On‐Demand Chemical Spaces for Enhanced Fragment Follow‐Up
Penner, P., Henry, C., Schröder, M., & Vulpetti, A. (2026) · ChemMedChem · doi:10.1002/cmdc.70333 · Cited by 1
State-Space Compression Enables Desktop-Scale Hit Discovery for Intrinsically Disordered α-SynucleinPreprint
Kim, D. H., Khenmedekh, G.-O., Park, I. Y., & Kim, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733879
“Rather than accelerating the scorer or hierarchically pruning the docking tree 20 , ISTP-DPISO DrugEngine removes molecules that never require scoring; therefore, we frame compression, not scoring, as the primary lever for billion-scale physics-based discovery.”
Library Docking for Cannabinoid-2 Receptor Ligands
Rachman, M. M., Iliopoulos‐Tsoutsouvas, C., Sacco, M. D., Xu, X., Wu, C.-G., Santos, E., Glenn, I., Paris, L., Cahill, M. K., Ganapathy, S., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00835
Self-citation
Circumventing the Synthesizability Problem in Generative Molecular Design
Weller, J. A., Li, J., Jiang, Y., & Rohs, R. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00998
Automated Parallel Synthesis Accelerates Virtual Screening Hit Discovery
McKenna, S. M., Šícho, M., van der Horst, C., Maasland, J., van der Nol, E., Turco, G., Bernatavicius, A., van Westen, G. J. P., Heitman, L. H., & Pomplun, S. J. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c05055
Chemical Distance-Based Acceleration of Large Library Docking with ChemSTEP
Mailhot, O., Holland, K. L., Paris, L., Radchenko, D. S., Moroz, Y. S., Irwin, J. J., & Shoichet, B. K. (2026) · ACS Central Science · doi:10.1021/acscentsci.6c00396
Self-citation
From virtual screening to selective angiotensin II type 2 receptor ligands: discovery of a novel scaffold
Patel, J. Z., Sandberg, L., Wannberg, J., Söderström, M., Backlund, M., Gising, J., Gravenfors, Y., Hallberg, M., Isaksson, R., & Larhed, M. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103660
“…PD123,319 / EMA401 to aid our continued exploration of structural requirements for efficient binding to the AT 2 R. Virtual screening has in recent years been more widely explored to guide new synthetic endeavors, support repurposing of drugs, and lowering costs of drug discovery campaigns [47,48].”
Prioritizing neuroactive ligands using motif-guided virtual discovery and zebrafish profiling
Ginsparg, A. B., Martinez, J. A., Patel, I. U., Buton, A., Lee, L., Sarwar, R., Moretti, R., Puig, S., & Thyme, S. B. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00058-1
Toward targeted covalent inhibition of Cruzipain for the treatment of Chagas disease
Canepa, J. I. E., Ribone, S. R., GRICH, A., Cerutti, J. P., & Quevedo, M. A. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130744
Domain generalization meets mutual bi-attention: A novel approach to drug-target prediction
Yang, J., Li, W., Qian, K., & Cheng, Z. (2026) · Neurocomputing · doi:10.1016/j.neucom.2026.134626
Generative virtual screening: from search to generate and back
Thomas, M. C., Astudillo, R., Raouf, Y. S., Navarro, C., Fabritiis, G. D., & Bender, A. (2026) · Digital Discovery · doi:10.1039/d6dd00025h
New paradigm of q-CAR drug development targeting disease-specific protein conformations
Ye, L. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00057-2 · Cited by 1
“The virtual compound libraries can contain billions of commercially available or synthetically on-demand accessible molecules, such as V-SYNTHES 56 , Enam-ine REAL 57 , ZINC22 58 , PubChem 59 , and ChEMBL 60 , partially listed in Table 1.”
Zipf-like Statistical Regularities in Molecular Sequence Representations for Chemical Language Models
Liu, A., Fang, C., Li, Y., Wang, Z., Qi, T., & Hu, G. (2026) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6c02089
AI-powered medicinal chemistry and translational drug development
Kaicheng, U., Zhang, S. M., Yu, Z., Zhang, Z., Zhang, J., He, C., Liu, A., Chen, R., Wang, S., Yan, L., et al. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01469g
Machine Learning‐Aided Small‐Molecule Virtual Screening: Recent Advances and Future Perspectives
Wang, Y., Bansal, N., Wa, S., Sciabola, S., & Wang, Y. (2026) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.70084
Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach
Protopopov, M., Semenenko, O., Vasylchuk, M., Sadybekov, A., Sadybekov, A. A., Horbatok, K., Hrabovskyi, O., Kapeliukha, A., Nazarova, A. L., Radchenko, D. S., et al. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00067-0
“As described before 14,32 the 2-component and 3-component reaction libraries were screened separately.”
Self-citation
Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation
Li, L., Soriano, L. D., Kedir, W. M., Hoch, F. L., & Loke, D. K. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00498-1
“The figure was created using Adobe Illustrator 2023 blocks [68, 69].”
Influential
Application of emerging technologies in the antiviral field
Zhang, X., Zhang, L., Guo, T., Du, W., Wang, S., & Li, Y. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106529
Big Data and Artificial Intelligence in Cancer Drug Discovery: Promise, Challenges, and Emerging Opportunities
Singhera, F. U., Overhulse, J. M., Lee, T. M., Katz, J. G., Lee, J. S. H., & McKenna, C. E. (2026) · Cancers · doi:10.3390/cancers18182939
Machine Learning Prediction of Docking Scores for 616 Million ZINC15 Compounds: Accuracy and Speedup vs. Model and InfrastructurePreprint
Dunárová, A., Gall, M., Matúška, J., Pitoňák, M., Štekláč, M., & Bučinský, L. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7607815

Authors: Sadybekov, A. A., Sadybekov, A. V., Liu, Y., Iliopoulos-Tsoutsouvas, C., Huang, X.-P., Pickett, J., Houser, B., Patel, N., Tran, N. K., Tong, F., Zvonok, N., Jain, M. K., Savych, O., Radchenko, D. S., Nikas, S. P., Petasis, N. A., Moroz, Y. S., Roth, B. L., Makriyannis, A., & Katritch, V.
Affiliations: University of Southern California (US)
University of North Carolina at Chapel Hill (US)
Northeastern University (US)
Enamine (Ukraine) (UA)
Taras Shevchenko National University of Kyiv (UA)
Corresponding author: Roth, Bryan L.
Makriyannis, Alexandros
Katritch, Vsevolod
ORCID: Sadybekov, Arman A.
Sadybekov, Anastasiia V.
Liu, Yongfeng
Huang, Xi-Ping
Pickett, Julie
Patel, Nilkanth
Tran, Ngan K.
Zvonok, Nikolai
Jain, Manish K.
Savych, Olena
Radchenko, Dmytro S.
Nikas, Spyros P.
Petasis, Nicos A.
Moroz, Yurii S.
Roth, Bryan L.
Makriyannis, Alexandros
Katritch, Vsevolod
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2021-12-15
Volume: 601
Issue: 7893
Pages: 452-459
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-021-04220-9
PMC: PMC9763054
OpenAlex: W4200233821
Cited by: 417
References: 43
Citations by year: 2026: 65 · 2025: 96 · 2024: 119 · 2023: 88 · 2022: 46 · 2021: 2
FWCI: 33.74
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
UNC Libraries
Funders: National Institute of Mental Health (R01MH112205)
National Institute on Drug Abuse (R01DA041435, R01DA045020, R37DA045657)
National Institute of General Medical Sciences (GM118289, T32GM118289)
National Institute of Diabetes and Digestive and Kidney Diseases (U24DK116195)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords: structure-based virtual screening, cannabinoid receptor antagonists, cannabinoid receptor ligands, lead compound identification
MeSH terms: Algorithms, Ligands, Combinatorial Chemistry Techniques, Libraries, Digital, rho-Associated Kinases, Drug Discovery, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks